Skip to main content

Table 6 Comparison of pharmacological treatments at the time of the index AMI event and at interview 2 years after AMI

From: Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome

 

At AMI

At interview

Aspirin n = 200 (%)

199 (99.5)

183 (91.5)

Beta-blocker n = 200 (%)

187 (93.5)

166 (83.0)

ACE-inhibitor or Angiotensin receptor blocker n = 200 (%)

177 (88.5)

153 (76.5)

Statin n = 200 (%)

193 (96.5)

177 (88.5)

Clopidogrel/prasugrel n = 200 (%)

179 (89.5)

11 (5.5)

  1. AMI acute myocardial infarction, ACE angiotensin-converting enzyme